MDxHealth has 4 validated testing products with one more in the clinical pipeline. All are focused specifically on urology. The company expects to do ~$65-$70M of sales in 2023, but the valuation is a ...

BOSTON--(BUSINESS WIRE)--Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, and Solaris Health, the nation’s leading ...

Testing for genetic mutations in urine can detect bladder cancer years before the disease shows clinical symptoms, new research has shown. The study, by researchers from France, Iran and the United ...

Point of care (POC) testing refers to a laboratory assay that can be performed outside of a centralized facility, with results available to the physician and patient within minutes. One of the most ...